This Antidepressant Recalled in France Due to Impurities Classified as Carcinogens
Summary by Le Huffington Post
1 Articles
1 Articles
The Medicine Agency has announced that this antidepressant, prescribed to 5,000 patients in France, including a majority of seniors, will be withdrawn from the market by the end of 2026 due to its composition.
·Paris, France
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium